Home » CLINICAL TRIAL OF MET'S MICROCAN SYRINGE SUCCESSFUL
CLINICAL TRIAL OF MET'S MICROCAN SYRINGE SUCCESSFUL
Micromedic Technologies notified the Tel Aviv Stock Exchange that its subsidiary, Microvascular Eye Technology successfully completed clinical trials in France of its MicroCan, a device that directly delivers therapeutic agents to the retinal blood vessel. The trials restored vision of a person suffering from retinal vein occlusion. Two of the three patients in the trial were treated with the device alone, without medication. The third patient, injected with a drug through the MicroCan, had vision restored to a functional level after three weeks.
Globes Online (http://www.globes.co.il/serveen/globes/docview.asp?did=1000032249)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May